{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:17:51Z","timestamp":1792819071713,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurophysiologie Clinique"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.neucli.2019.12.001","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T09:24:12Z","timestamp":1578561852000},"page":"47-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Nerve conduction, circulating osteopontin and taxane-induced neuropathy in breast cancer patients"],"prefix":"10.1016","volume":"50","author":[{"given":"Chiara","family":"Pizzamiglio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8662-9656","authenticated-orcid":false,"given":"Paolo","family":"Ripellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Prandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nausicaa","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Saggia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4115-3874","authenticated-orcid":false,"given":"Gionata","family":"Strigaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier","family":"Luigi Foglio Bonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristoforo","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cantello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neucli.2019.12.001_bib0225","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/ejp.1169","article-title":"Blocking of cytokines signalling attenuates evoked and spontaneous neuropathic pain behaviours in the paclitaxel rat model of chemotherapy-induced neuropathy","volume":"22","author":"Al-Mazidi","year":"2018","journal-title":"Eur J Pain"},{"key":"10.1016\/j.neucli.2019.12.001_bib0230","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41586-018-0467-6","article-title":"Required growth facilitators propel axon regeneration across complete spinal cord injury","volume":"561","author":"Anderson","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.neucli.2019.12.001_bib0235","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11060-007-9438-8","article-title":"Peripheral neuropathy due to paclitaxel: study of the temporal relationships between the therapeutic schedule and the clinical quantitative score (QST) and comparison with neurophysiological findings","volume":"86","author":"Augusto","year":"2008","journal-title":"J Neurooncol"},{"key":"10.1016\/j.neucli.2019.12.001_bib0240","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10549-016-3939-0","article-title":"Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk","volume":"159","author":"Bao","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.neucli.2019.12.001_bib0245","doi-asserted-by":"crossref","first-page":"9345495","DOI":"10.1155\/2016\/9345495","article-title":"Thrombin cleavage of osteopontin modulates its activities in human cells in vitro and mouse experimental autoimmune encephalomyelitis in vivo","volume":"2016","author":"Boggio","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.neucli.2019.12.001_bib0250","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.neucli.2019.12.001_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/4049098","article-title":"Osteopontin at the crossroads of inflammation and tumor progression","volume":"2017","author":"Castello","year":"2017","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.neucli.2019.12.001_bib0260","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/annonc\/mdh348","article-title":"Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy","volume":"15","author":"Cavaletti","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.neucli.2019.12.001_bib0265","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1529-8027.2007.00141.x","article-title":"The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale","volume":"12","author":"Cavaletti","year":"2007","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neucli.2019.12.001_bib0270","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.410350310","article-title":"Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies","volume":"35","author":"Chaudhry","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neucli.2019.12.001_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0145816","article-title":"Identifying predictors of taxane-induced peripheral neuropathy using mass spectrometry-based proteomics technology","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neucli.2019.12.001_bib0280","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/WNP.0b013e3182767d3b","article-title":"Electrophysiological features of taxane-induced polyneuropathy in patients with breast cancer","volume":"30","author":"Chen","year":"2013","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.neucli.2019.12.001_bib0285","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/archneurol.2007.33","article-title":"Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis","volume":"65","author":"Chowdhury","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neucli.2019.12.001_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/7675437","article-title":"Osteopontin bridging innate and adaptive immunity in autoimmune diseases","volume":"2016","author":"Clemente","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.neucli.2019.12.001_bib0295","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/1673-5374.198980","article-title":"Insights into the protective role of immunity in neurodegenerative disease","volume":"12","author":"Comi","year":"2017","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.neucli.2019.12.001_bib0300","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/CAD.0000000000000093","article-title":"Cellular and clinical pharmacology of the taxanes docetaxel and paclitaxel\u2013a review","volume":"25","author":"de Weger","year":"2014","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.neucli.2019.12.001_bib0305","doi-asserted-by":"crossref","first-page":"43718","DOI":"10.1038\/srep43718","article-title":"Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis","volume":"7","author":"Dianzani","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.neucli.2019.12.001_bib0310","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pain.2004.01.021","article-title":"Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients","volume":"109","author":"Dougherty","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.neucli.2019.12.001_bib0315","first-page":"420","article-title":"Full-length osteopontin and its splice variants as modulators of chemoresistance and radioresistance","volume":"54","author":"Gimba","year":"2019","journal-title":"Int J Oncol"},{"key":"10.1016\/j.neucli.2019.12.001_bib0320","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1200\/JCO.2015.66.2346","article-title":"Comorbidities and risk of chemotherapy-induced peripheral neuropathy among participants 65 years or older in southwest oncology group clinical trials","volume":"34","author":"Hershman","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neucli.2019.12.001_bib0325","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/jnr.10099","article-title":"Osteopontin: a novel axon-regulated Schwann cell gene","volume":"67","author":"Jander","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neucli.2019.12.001_bib0330","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1007\/s11136-017-1626-1","article-title":"Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)","volume":"26","author":"Kieffer","year":"2017","journal-title":"Qual Life Res"},{"key":"10.1016\/j.neucli.2019.12.001_bib0335","series-title":"Electrodiagnosis in diseases of nerve and muscle. Principles and practice","author":"Kimura","year":"2014"},{"key":"10.1016\/j.neucli.2019.12.001_bib0340","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.1158\/1078-0432.CCR-13-0572","article-title":"Defining risks of taxane neuropathy: insights from randomized clinical trials","volume":"19","author":"Kudlowitz","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.neucli.2019.12.001_bib0345","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1212\/WNL.39.3.368","article-title":"Taxol produces a predominantly sensory neuropathy","volume":"39","author":"Lipton","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.neucli.2019.12.001_bib0350","series-title":"Memorandum no. 45","article-title":"Aids to examination of the peripheral nervous system","author":"Medical Research","year":"1976"},{"key":"10.1016\/j.neucli.2019.12.001_bib0355","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/1471-2407-8-330","article-title":"Quality of life in patients with breast cancer before and after diagnosis: an eighteen months follow-up study","volume":"8","author":"Montazeri","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.neucli.2019.12.001_bib0360","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10549-017-4437-8","article-title":"Long-term peripheral neuropathy symptoms in breast cancer survivors","volume":"166","author":"Mustafa Ali","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.neucli.2019.12.001_bib0365","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.humpath.2013.10.015","article-title":"Association of increased osteopontin and splice variant-c mRNA expression with HER2 and triple-negative\/basal-like breast carcinomas subtypes and recurrence","volume":"45","author":"Ortiz-Mart\u00ednez","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.neucli.2019.12.001_bib0370","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/mus.21874","article-title":"Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel-induced neuropathy","volume":"43","author":"Park","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neucli.2019.12.001_bib0375","first-page":"419","article-title":"Chemotherapy-induced peripheral neurotoxicity: a critical analysis","volume":"63","author":"Park","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.neucli.2019.12.001_bib0380","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.expneurol.2006.07.022","article-title":"Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells","volume":"203","author":"Peters","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neucli.2019.12.001_bib0385","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.ejca.2005.02.012","article-title":"The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20","volume":"41","author":"Postma","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.neucli.2019.12.001_bib0390","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s10067-014-2665-4","article-title":"Osteopontin circulating levels correlate with renal involvement in systemic lupus erythematosus and are lower in ACE inhibitor-treated patients","volume":"33","author":"Quaglia","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.neucli.2019.12.001_bib0395","first-page":"1065","article-title":"Paclitaxel toxicity in post-mitotic dorsal root ganglion (DRG) cells","volume":"26","author":"Scuteri","year":"2006","journal-title":"Anticancer Res"},{"key":"10.1016\/j.neucli.2019.12.001_bib0400","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuropharm.2018.08.040","article-title":"Paclitaxel-induced HMGB1 release from macrophages and its implication for peripheral neuropathy in mice: evidence for a neuroimmune crosstalk","volume":"141","author":"Sekiguchi","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neucli.2019.12.001_bib0405","first-page":"3355","article-title":"Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial","volume":"20","author":"Shimozuma","year":"2012","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.neucli.2019.12.001_bib0410","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.acthis.2012.08.004","article-title":"Osteopontin as a two-sided mediator in acute neuroinflammation in rat models","volume":"114","author":"Shin","year":"2012","journal-title":"Acta Histochem"},{"key":"10.1016\/j.neucli.2019.12.001_bib0415","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2013.2813","article-title":"Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial","volume":"309","author":"Smith","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.neucli.2019.12.001_bib0420","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/bjs.18004116714","article-title":"The relative susceptibility to injury of the medial and lateral popliteal divisions of the sciatic nerve","volume":"41","author":"Sunderland","year":"1953","journal-title":"Br J Surg"},{"key":"10.1016\/j.neucli.2019.12.001_bib0425","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/mcne.1999.0814","article-title":"Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: a novel neuronal marker of nerve injury","volume":"15","author":"Tsujino","year":"2000","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.neucli.2019.12.001_bib0430","first-page":"145","article-title":"A retrospective electrodiagnostic evaluation of footdrop in 303\u00a0patients","volume":"29","author":"Van Langenhove","year":"1989","journal-title":"Electromyogr Clin Neurophysiol"},{"key":"10.1016\/j.neucli.2019.12.001_bib0435","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1523\/JNEUROSCI.3822-13.2014","article-title":"Novel roles for osteopontin and clusterin in peripheral motor and sensory axon regeneration","volume":"34","author":"Wright","year":"2014","journal-title":"J Neurosci"},{"key":"10.1016\/j.neucli.2019.12.001_bib0440","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41419-018-0391-6","article-title":"The role of osteopontin in the progression of solid organ tumour","volume":"9","author":"Zhao","year":"2018","journal-title":"Cell Death Dis"}],"container-title":["Neurophysiologie Clinique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0987705319304241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0987705319304241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T09:01:54Z","timestamp":1760864514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0987705319304241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0987705319304241"],"URL":"https:\/\/doi.org\/10.1016\/j.neucli.2019.12.001","relation":{},"ISSN":["0987-7053"],"issn-type":[{"value":"0987-7053","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nerve conduction, circulating osteopontin and taxane-induced neuropathy in breast cancer patients","name":"articletitle","label":"Article Title"},{"value":"Neurophysiologie Clinique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neucli.2019.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}